Further, MECOM has been associated with aggressiveness of intrahepatic cholangiocarcinoma and also functions as prognostic biomarker in glioblastoma multiforme, lung squamous cell carcinoma, clear cell renal carcinoma, and lung adenocarcinoma [12, 13]. This evidence concerns the gene MECOM and squamous cell lung carcinoma.